Literature DB >> 15764345

The 70 kilodalton heat shock protein is an inhibitor of apoptosis in prostate cancer.

E L Jones1, M J Zhao, M A Stevenson, S K Calderwood.   

Abstract

The 70 kD heat shock protein (HSP70) plays essential cellular roles in mediating intracellular protein folding and protecting cells from proteotoxic stress. This study has examined the role of HSP70 in the expression of apoptosis in prostate carcinoma cells. Apoptosis was negatively correlated with HSP70 expression in PC-3 cells heat shocked in vivo. Further experiments carried out on an in vitro reconstituted system with isolated nuclei and cytoplasm from PC-3 cells showed that purified HSP70 directly inhibits apoptosis in a dose-dependant manner. Therefore, the potential role of depletion of intracellular HSP70 was examined as a means of inducing apoptosis in PC-3 cancer cells. Depletion of HSP70 by two independent strategies, either with anti-sense oligonucleotides directed against HSP70 mRNA or with the bioflavinoid drug quercetin, led to apoptosis in the absence of stress. In addition, quercetin pre-treatment synergistically enhanced apoptosis in combination with heat shock. Thus, HSP70 plays a physiological role in tumour cells as an inhibitor of apoptosis occurring both spontaneously and after stress and is a potential target for apoptosis-based cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15764345     DOI: 10.1080/02656730410001721807

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  17 in total

Review 1.  [Stress proteins in prostate cancer. Challenge and promise].

Authors:  B A Hadaschik; S W Melchior; R D Sowery; A I So; M E Gleave
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

2.  The role of stress proteins in prostate cancer.

Authors:  Alan So; Boris Hadaschik; Richard Sowery; Martin Gleave
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

Review 3.  Mechanisms of combined action of different chemopreventive dietary compounds: a review.

Authors:  Theo M de Kok; Simone G van Breda; Margaret M Manson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

Review 4.  Tumor-associated antigen arrays for the serological diagnosis of cancer.

Authors:  Carlos A Casiano; Melanie Mediavilla-Varela; Eng M Tan
Journal:  Mol Cell Proteomics       Date:  2006-05-29       Impact factor: 5.911

5.  Intracell Heat Shock Protein 70 Expression and Nasopharyngeal Carcinoma Stage.

Authors:  Elida Mustikaningtyas; Sri Herawati Juniati; A C Romdhoni
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-03-23

6.  Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo.

Authors:  Dan Tang; Md Abdul Khaleque; Ellen L Jones; Jimmy R Theriault; Cheng Li; Wing Hung Wong; Mary Ann Stevenson; Stuart K Calderwood
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

Review 7.  Heat shock proteins in breast cancer progression--a suitable case for treatment?

Authors:  Stuart K Calderwood
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 8.  Hyperthermia as an immunotherapy strategy for cancer.

Authors:  Joseph J Skitzki; Elizabeth A Repasky; Sharon S Evans
Journal:  Curr Opin Investig Drugs       Date:  2009-06

9.  Phosphorylation of eIF2alpha in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase.

Authors:  Azmi Yerlikaya; Scot R Kimball; Bruce A Stanley
Journal:  Biochem J       Date:  2008-06-15       Impact factor: 3.857

Review 10.  Heat shock proteins in animal neoplasms and human tumours--a comparison.

Authors:  Mariarita Romanucci; Tania Bastow; Leonardo Della Salda
Journal:  Cell Stress Chaperones       Date:  2008-03-12       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.